NDAIONTOPHORESIS, TRANSDERMALSYSTEM
Approved
May 2006
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Data completeness
3/8 — Basic
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IONSYS is a transdermal iontophoretic system delivering fentanyl hydrochloride for acute pain management in hospital and healthcare settings. It uses electrical current to enable patient-controlled transdermal fentanyl delivery, offering rapid onset compared to traditional IV administration. The device-drug combination addresses post-operative and acute care pain with reduced nursing workload.
Peak6.6 years to LOE
Product is in peak commercial phase with established market presence; team focus likely on operational efficiency, payer relationships, and hospital formulary management rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery
Started Nov 2011
0Cardiac Surgery
An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery
Started May 2008
108 enrolled
Pain, Postoperative
Career Relevance
IONSYS careers focus on hospital and health system relationships, formulary management, and payer negotiations rather than field primary care sales. The peak lifecycle stage and zero linked job count suggest a stable, mature team with selective hiring for replacement or specialized roles.
Worked on IONSYS at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.